Skip to content
  • Home
Menu
  • Home
Login

Therapeutic Goods Administration (TGA)

  1. Home>
  2. Arts>
  3. Therapeutic Goods Administration (TGA)>
  4. Page 2

Nitrosamine and Nitroso-structure impurities acceptable intakes update

  • Post author:
  • Post published:19/02/2025
  • Post category:

Nitrosamines and other nitroso-structure impurities in medicinesWe have published updated information for nitrosamine impurities and other nitroso-structure impurities in medicines consistent with recent EMA updated information. The changes include additional…

Continue ReadingNitrosamine and Nitroso-structure impurities acceptable intakes update

Product Information safety updates – February 2025

  • Post author:
  • Post published:13/02/2025
  • Post category:

When new safety information for medicines is identified, the Therapeutic Goods Administration (TGA) works with the sponsors to update Product Information (PI) to ensure that health professionals and consumers have…

Continue ReadingProduct Information safety updates – February 2025

TGA publishes literature review of sunscreen ingredients

  • Post author:
  • Post published:05/02/2025
  • Post category:

The TGA has released a literature review of certain active ingredients used in sunscreens. Literature search and summaries for seven sunscreen active ingredients as of 4 February 2025 [PDF, 835.28…

Continue ReadingTGA publishes literature review of sunscreen ingredients

More prominent safety warnings about the neuropsychiatric effects of montelukast

  • Post author:
  • Post published:17/01/2025
  • Post category:

SummaryMontelukast is a prescription medicine used to prevent and treat chronic asthma in adults and children aged 2 years and older, and for symptomatic seasonal allergic rhinitis (hay fever). Additional…

Continue ReadingMore prominent safety warnings about the neuropsychiatric effects of montelukast

Consent relating to listed medicines that contain whole live microorganisms as an active ingredient

  • Post author:
  • Post published:15/01/2025
  • Post category:

I, Avinash Clarke, as delegate of the Secretary of the Department of Health and Aged Care under sections 14 and 14A of the Therapeutic Goods Act 1989, give the following…

Continue ReadingConsent relating to listed medicines that contain whole live microorganisms as an active ingredient
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Go to the next page
  • Become an employer
    • Post Your Job
    • Business Account
    • Resource Center
    • Community
Copyright - OceanWP Theme by OceanWP

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Verify OTP

An OTP has been sent to your registered email address.

Enter your Email

Enter your email id below to signup.

Verify Email

Enter the 4-digit OTP shared on your email

Edit

Tell us more about yourself

Enter your name and organization

Select your work area

This will helps us to provide you with better personalisation and experience

Select your country

This will helps us to provide you with better personalisation and experience

All set.

Welcome, ! Your GRI account has been successfully set up.
Visit Dashboard
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales